ONCOR: design of the Dutch cardio-oncology registry
Autor: | H C Hassing, Pieter A. Doevendans, A M Stevense-den Boer, C. Liesting, Folkert W. Asselbergs, E G M Olde Bijvank, Jeroen Schaap, Marijke Linschoten, D J W van Kessel, Maarten J. Cramer, F Alsemgeest, K Urgel, M C Post, Arco J. Teske, Alexander J Wardeh, Janine A. M. Kamphuis, Olivier C. Manintveld |
---|---|
Přispěvatelé: | Cardiology |
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Research design
medicine.medical_specialty Data collection business.industry Incidence (epidemiology) Cancer Original Article – Study Design Article medicine.disease Subspecialty Cardio-oncology SDG 3 - Good Health and Well-being medicine Registries Cardio oncology Cardiology and Cardiovascular Medicine Intensive care medicine business Adverse effect Cohort study |
Zdroj: | Netherlands heart journal, 29(5), 288-294. Bohn Stafleu van Loghum Netherlands Heart Journal, 29(5), 288-294. Bohn Stafleu van Loghum Netherlands Heart Journal |
ISSN: | 1568-5888 |
Popis: | Background The relative new subspecialty ‘cardio-oncology’ was established to meet the growing demand for an interdisciplinary approach to the management of cancer therapy–related cardiovascular adverse events. In recent years, specialised cardio-oncology services have been implemented worldwide, which all strive to improve the cardiovascular health of cancer patients. However, limited data are currently available on the outcomes and experiences of these specialised services, and optimal strategies for cardio-oncological care have not been established. Aim The ONCOR registry has been created for prospective data collection and evaluation of cardio-oncological care in daily practice. Methods Dutch hospitals using a standardised cardio-oncology care pathway are included in this national, multicentre, observational cohort study. All patients visiting these cardio-oncology services are eligible for study inclusion. Data collection at baseline consists of the (planned) cancer treatment and the cardiovascular risk profile, which are used to estimate the cardiotoxic risk. Information regarding invasive and noninvasive tests is collected during the time patients receive cardio-oncological care. Outcome data consist of the incidence of cardiovascular complications and major adverse cardiac events, and the impact of these events on the oncological treatment. Discussion Outcomes of the ONCOR registry may aid in gaining more insight into the incidence of cancer therapy–related cardiovascular complications. The registry facilitates research on mechanisms of cardiovascular complications and on diagnostic, prognostic and therapeutic strategies. In addition, it provides a platform for future (interventional) studies. Centres with cardio-oncology services that are interested in contributing to the ONCOR registry are hereby invited to participate. |
Databáze: | OpenAIRE |
Externí odkaz: |